Oct 2026· Stem Cell Reports· pp.
103112
· 0 citations· 54 references
Medicine
TL;DR
The KOLF2.1J human induced pluripotent stem cell line was created as a reference for neurological disease modeling and 37 additional SVs were identified using long-read sequencing and optical genome mapping, finding one of the known SVs contained a previously undetected overlap with RYBP, a neurodevelopmental gene.
Abstract
The KOLF2.1J human induced pluripotent stem cell (iPSC) line was created as a reference for neurological disease modeling. Previous genotyping efforts identified several large structural variants (SVs), raising questions about their potential impact on neuronal differentiation. Here, we identified 37 additional SVs using long-read sequencing and optical genome mapping. Additionally, we found that one of the known SVs contained a previously undetected overlap with RYBP, a neurodevelopmental gene. To assess the functional consequences of these SVs, we performed single-cell RNA sequencing of day 90 forebrain organoids derived from KOLF2.1J and two independent control iPSC lines. While cell-type composition was preserved, multiple SV-affected genes were differentially expressed and cell-cell adhesion and synapse-related processes were enriched in KOLF2.1J organoids. These findings highlight the importance of robust genetic characterization and multi-line validation for reliable iPSC-based modeling.
Schwann cells are vital to development and maintenance of the peripheral nervous system, and their dysfunction has been implicated in a range of neurological and neoplastic disorders, including
NF2
-related schwannomatosis (
NF2
-SWN). We have developed a human induced pluripotent stem cells (hiPSCs) model for...
Olivia Lazaro, Si-Hong Li, Jacob S. Smiley et al.· Scientific Reports· 0 citations
Systematic molecular characterization of human induced pluripotent stem cell (iPSC) lines carrying disease-associated mutations is needed to distinguish disease-related biology from variation in cell state, genomic integrity, and genome-editing history, yet such systematic characterization is uncommon. Here, we profile...
Le Qi, T. Bertucci, Susan Borden et al.· Neuron· 0 citations
This patient-derived iPSC-based model provides a platform for investigating the biological significance of neural lineage-specific eHHV-6 transcripts and may facilitate interpretation of HHV-6 DNA detection in patients with eHHV-6 by enabling studies of cell type-dependent viral transcription.
Hiroki Miura, Tomoki Inagaki, T. Ohye et al.· Journal of Infectious Diseas...· 0 citations
This study establishes a cost- and time-efficient approach for generating functional OLs from iPSCs, with broad applicability for disease modeling, drug screening, and the development of regenerative therapies.
I. Bienjonetti, Vincent Roy, M. Beaudet et al.· Journal of Neuroscience Rese...· 0 citations
Purpose of ResearchThe generation of iPSC lines expressing 21, 56 and 79 glutamine repeats within the HTT protein and homozygous KO of HTT in the KOLF2.1J background as an additional disease series within the iPSC Neurodegenerative Disease Initiative (iNDI) collection.Major FindingsAll iPSCs, even those expressing long...
Lisa Salazar, Mara S. Burns, Jennifer T. Stocksdale et al.· Journal of Huntington's Dise...· 0 citations
How iPSC-based disease modeling is evolving from a platform for mechanism discovery toward a test bed for therapeutic epigenome engineering is discussed and the major challenges that must be addressed are outlined before epigenome editing can be translated to patients with imprinting disorders.
A. Nemoto, Hideyuki Okano· Neurosciences research· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.